Avivomed, Inc.

About

Avivomed, Inc. is a medical device company founded in 2020 and based in Roseville, Minnesota, with additional operations in Ireland. The company specializes in developing and commercializing next-generation neuromodulation technology platforms aimed at treating chronic diseases, particularly obstructive sleep apnea (OSA). Avivomed focuses on creating minimally invasive therapies to meet the clinical needs of large patient populations. The company collaborates with engineers, product developers, and leading physicians to advance its innovative implantable devices. Avivomed raised $32 million in a Series A financing round in December 2021, supported by notable investors. The team consists of experienced professionals, including CEO Dan Brounstein and co-founders Lynn Elliott and Mudit Jain, PhD, MBA. With a dedicated workforce, Avivomed is committed to improving the quality of life for patients suffering from chronic conditions.